Business Combinations - Schedule of Purchase Price (Detail) - BioMedomics, Inc $ in Thousands |
Nov. 12, 2025
USD ($)
|
|---|---|
| Business Combination [Line Items] | |
| Purchase price | $ 2,865 |
| Transaction expenses | 403 |
| Debt paid off | 330 |
| Earnout contingent consideration | 233 |
| Expense fund | 40 |
| Initial aggregate purchase price | $ 3,871 |
| X | ||||||||||
- Definition Business Combination, Debt Paid Off No definition available.
|
| X | ||||||||||
- Definition Business Combination, Expense Fund No definition available.
|
| X | ||||||||||
- Definition Amount of transaction cost incurred to effect business combination. Excludes separately recognized transaction and indirect cost. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|